Skip to main content
SpringerLink
Log in

Newborn screening for cystic fibrosis: Science, legislation, and human values

  • Commentary
  • Published:
Journal of Inherited Metabolic Disease

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  • Anonymous (2001) Screening brief: Neonatal screening for cystic fibrosis. J Med Screen 8: 51; Arch Dis Child 84: 449.

    Article  Google Scholar 

  • Boyne J, Evans S, Pollitt RJ, Taylor CJ, Dalton A (2000) Many AF508 heterozygote neonates with transient hypertrypsinaemia have a second, mild CFTR mutation. J Med Genet 37: 543-547.

    Article  PubMed  CAS  Google Scholar 

  • Dhondt JL, Farriaux JP, Briard ML, Boschetti R, Fr6zal J (1993). Results of pilot screening activities in the French neonatal screening program cystic fibrosis, congenital adrenal hyperplasia and sickle cell disease. Screening 2: 87–89.

    Article  Google Scholar 

  • Eaton RB, Comeau AM, Zytkovicz TH, Larson C (2002) Newborn screening: New developments in a proven field. Clin Lab Sci 15: 239–244.

    PubMed  Google Scholar 

  • Farriaux JP, Vidailhet M, Briard ML, Belot V, Dhondt JL. (2003) Neonatal screening for cystic fibrosis: France rises to the challenge. J Inherit Metab Dis 26: 000-000.

    Article  CAS  Google Scholar 

  • McCormick J, Green MW, Mehta G, Culross F, Mehta A (2002) Demographics of the UK cystic fibrosis population: Implications for neonatal screening. Eur J Hum Genet 10: 583-590.

    Article  PubMed  Google Scholar 

  • Merelle ME, Huisman J, Alderden-van der Vecht A et al (2003) Early versus late diagnosis: psychological impact on parents of children with cystic fibrosis. Pediatrics 111: 346-500.

    Article  PubMed  Google Scholar 

  • Pollitt RJ, Dalton A, Evans S, Hughes HN, Curtis D (1997) Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step. J Med Screen 4: 23-28.

    PubMed  CAS  Google Scholar 

  • Ranieri E, Ryall RG, Morris CP et al (1991) Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis. Br Med J 302: 1237–1240.

    Article  CAS  Google Scholar 

  • Rosenstein BJ (2003) Non-classical cystic fibrosis: a clinical conundrum. Pediatr Pulmonol 36: 10–12.

    Article  PubMed  Google Scholar 

  • Travert G (1988) Analyse de l'exp6rience mondiale de d6pistage neonatal de la mucoviscidose par dosage de la trypsine immunoreactive sanguine. In Travert G, ed. Mucoviscidose. Dtpistage neonatal et prise en charge precose. University Caen, 1–23.

  • Wilfond B, Rosenberg LS (2002) Ethical issues in cystic fibrosis screening: from data to public health policy. Curr Opin Pulm Med 8: 529-553.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Children's Hospital, Sheffield, S10 2TH, UK

    R. J. Pollitt

Authors
  1. R. J. Pollitt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pollitt, R.J. Newborn screening for cystic fibrosis: Science, legislation, and human values. J Inherit Metab Dis 26, 725–727 (2003). https://doi.org/10.1023/B:BOLI.0000009975.91855.cc

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:BOLI.0000009975.91855.cc

Search

Navigation